Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Usana Health Sciences Inc (USNA)
Price$14.34Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $925.3M | $854.5M | $921.0M | $998.6M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B | $918.5M | $790.5M | $718.2M | $648.7M | $581.9M | $517.6M | $436.9M |
| Gross profit | $724.4M | $693.3M | $744.3M | $804.7M | $968.6M | $925.5M | $873.4M | $988.5M | $867.9M | $825.9M | $758.8M | $649.7M | $590.7M | $532.9M | $480.2M | $422.2M | $347.1M |
| Gross margin | 78.29% | 81.13% | 80.82% | 80.58% | 81.63% | 81.57% | 82.33% | 83.12% | 82.87% | 82.09% | 82.61% | 82.19% | 82.26% | 82.15% | 82.53% | 81.55% | 79.45% |
| Research & development | $10.7M | $11.6M | $11.4M | $11.6M | $11.1M | $10.6M | $10.3M | $10.2M | $9.0M | $8.8M | $6.4M | $5.1M | $5.1M | $4.7M | $4.1M | $3.8M | — |
| Operating expenses | $687.0M | $627.0M | $651.2M | $697.1M | $798.4M | $749.0M | $727.2M | $800.2M | $735.4M | $687.3M | $617.2M | $533.6M | $474.0M | $434.7M | $403.0M | $353.9M | $296.3M |
| Operating income | $37.4M | $66.3M | $93.1M | $107.6M | $170.2M | $176.5M | $146.2M | $188.4M | $132.5M | $138.6M | $141.7M | $116.1M | $116.7M | $98.2M | $77.3M | $68.2M | $50.8M |
| Operating margin | 4.05% | 7.76% | 10.11% | 10.78% | 14.34% | 15.55% | 13.78% | 15.84% | 12.65% | 13.78% | 15.42% | 14.69% | 16.25% | 15.13% | 13.28% | 13.18% | 11.62% |
| EBITDA | $70.0M | $80.9M | $105.8M | $121.0M | $183.2M | $190.2M | $160.9M | $205.2M | $148.6M | $152.1M | $151.6M | $124.9M | $125.8M | $107.0M | $85.7M | $76.1M | $57.9M |
| EBITDA margin | 7.56% | 9.46% | 11.48% | 12.12% | 15.44% | 16.77% | 15.17% | 17.25% | 14.19% | 15.12% | 16.51% | 15.80% | 17.51% | 16.49% | 14.73% | 14.71% | 13.24% |
| Net income | $10.8M | $42.0M | $63.8M | $69.3M | $116.5M | $124.7M | $100.5M | $126.2M | $62.5M | $100.0M | $94.7M | $76.6M | $79.0M | $66.4M | $50.8M | $45.7M | $33.6M |
| Net profit margin | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% | 10.99% | 9.48% | 10.61% | 5.97% | 9.94% | 10.31% | 9.69% | 11.00% | 10.24% | 8.72% | 8.82% | 7.68% |
| Basic EPSper basic share | $0.58 | $2.20 | $3.31 | $3.60 | $5.78 | $5.89 | $4.44 | $5.24 | $2.57 | $4.14 | $3.72 | $2.90 | $1.44 | $1.14 | $0.83 | $0.74 | $0.55 |
| Diluted EPSper diluted share | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.41 | $5.12 | $2.53 | $3.99 | $3.59 | $2.80 | $1.39 | $1.11 | $0.82 | $0.72 | $0.54 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
WENTZ MYRON W / Gull Global Ltd | 7.41M |
Nantahala Capital Management, LLC | 1.62M |
BlackRock, Inc. | 1.55M |
PZENA INVESTMENT MANAGEMENT LLC | 1.21M |
RENAISSANCE TECHNOLOGIES LLC | 958.52K |
DIMENSIONAL FUND ADVISORS LP | 837.43K |
VANGUARD CAPITAL MANAGEMENT LLC | 487.37K |
Creative Planning | 417.97K |
AQR CAPITAL MANAGEMENT LLC | 408.09K |
VANGUARD PORTFOLIO MANAGEMENT LLC | 363.38K |
GEODE CAPITAL MANAGEMENT, LLC | 283.17K |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 272.21K |
STATE STREET CORP | 261.24K |
Nuveen, LLC | 239.48K |
AMERICAN CENTURY COMPANIES INC | 187.35K |
JACOBS LEVY EQUITY MANAGEMENT, INC | 180.57K |
TWO SIGMA INVESTMENTS, LP | 165.51K |
MORGAN STANLEY | 164.36K |
D. E. Shaw & Co., Inc. | 156.84K |
ACADIAN ASSET MANAGEMENT LLC | 147.66K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026Form 4 | Neidig BrentCHIEF COMMERCIAL OFFICER | SellCommon Stock | 5.0K | $19.45 | $97.3K | 0 |
| Jun 15, 2026Form 4 | Neidig BrentCHIEF COMMERCIAL OFFICER | SellCommon Stock | 909 | $20.01 | $18.2K | 5.0K |
| Jun 12, 2026Form 4 | Neidig BrentCHIEF COMMERCIAL OFFICER | SellCommon Stock | 1.6K | $20.15 | $32.3K | 5.9K |
| Jun 8, 2026Form 4 | Jones Paul A.CHIEF PEOPLE OFFICER | SellCommon Stock | 5.6K | $18.50 | $102.9K | 0 |
| Jun 1, 2026Form 4 | Fleming John TurmanDirector | SellCommon Stock | 2.5K | $17.93 | $43.9K | 4.2K |